Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
AMEX
Rexahn Pharmaceuticals, Inc. (RNN)
Rexahn Pharmaceuticals, Inc. (RNN) News

RNN

Rexahn Pharmaceuticals, Inc. (RNN)

Rexahn Pharmaceuticals, Inc.

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:RNN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next >>

Date	Time	Source	Headline	Symbol	Company
05/08/2014	9:00AM	Business Wire	Rexahn Announces Additional Data from Preclinical Studies of RX-3117	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
04/21/2014	9:00AM	Business Wire	Rexahn Presents Data from Preclinical Studies of RX-21101	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
04/18/2014	4:16PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
04/16/2014	4:19PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
04/10/2014	8:21AM	PR Newswire (US)	Brinson Patrick Re-launches Research Department	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
04/02/2014	9:00AM	Business Wire	Rexahn Pharmaceuticals to Present Data on RX-3117 & RX-21101 at the 2014 American Association for Clinical Research Annual Me...	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
04/01/2014	9:00AM	PR Newswire (US)	Active Equities Updates -- Research on Valero Energy, UTi Worldwide, SLM Corp., and Rexahn Pharma	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
03/28/2014	5:08PM	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
03/24/2014	8:00AM	Business Wire	Rexahn Pharmaceuticals Reports Fourth Quarter and Full-Year 2013 Financial Results and Recent Highlights	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
03/21/2014	4:19PM	Edgar (US Regulatory)	Annual Report (10-k)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
03/17/2014	8:00AM	Business Wire	Rexahn Pharmaceuticals to Present at the 2nd Annual Sachs Cancer Bio Partnering & Investment Forum in New York	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
03/11/2014	11:32AM	PR Newswire (US)	Investor-Edge.com Pre-market Biotech Picks: Rexahn Pharma, Amgen, Galena Biopharma, and MannKind	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
03/11/2014	8:00AM	Business Wire	Rexahn Announces Initial Results from Phase I Trial of SupinoxinTM (RX-5902) for Solid Cancer Tumors	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
03/04/2014	8:00AM	Business Wire	Rexahn Pharmaceuticals to Present at the 26th Annual ROTH Conference	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
03/03/2014	4:33PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
03/03/2014	4:26PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
03/03/2014	4:16PM	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
03/03/2014	8:00AM	Business Wire	Rexahn Pharmaceuticals Appoints Mark Carthy to Board of Directors	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
02/04/2014	8:00AM	Business Wire	Rexahn Pharmaceuticals to Present at the 16th Annual BIO CEO & Investor Conference	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
01/15/2014	8:59AM	Business Wire	Rexahn Announces $20 Million Registered Direct Offering	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
01/14/2014	9:00AM	Business Wire	Rexahn Initiates Phase IIa Clinical Trial of Archexin® in Patients with Metastatic Renal Cell Carcinoma	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
01/08/2014	8:00AM	Business Wire	Rexahn Initiates Phase Ib Clinical Trial of RX-3117 for Treatment of Solid Tumors	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
01/07/2014	8:00AM	Business Wire	Rexahn Pharmaceuticals to Present at the Biotech Showcase 2014	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
12/11/2013	8:00AM	Business Wire	Rexahn Receives Method Patent for Treatment of Solid Tumor Cancers for Supinoxin TM (RX-5902)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
11/19/2013	8:00AM	Business Wire	Rexahn Pharmaceuticals to Participate in Brean Capital 2013 Life Sciences Summit	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
11/14/2013	8:00AM	Business Wire	Rexahn Pharmaceuticals Reports Third Quarter Financial Results and Pipeline Update	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
11/14/2013	7:19AM	Dow Jones News	The Vanguard Group 3Q 13F: Largest Purchases -2-	AMEX:RNN	Rexahn Pharmaceuticals Inc.
11/14/2013	7:19AM	Dow Jones News	The Vanguard Group 3Q 13F: Largest Purchases	AMEX:RNN	Rexahn Pharmaceuticals Inc.
11/13/2013	4:16PM	Edgar (US Regulatory)	Quarterly Report (10-q)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.
10/16/2013	4:31PM	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:RNN	Rexahn Pharmaceuticals, Inc.

Showing the most relevant articles for your search:AMEX:RNN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next >>

New Momentum (PK)

Cann American (CE)

Therapeutic Solutions (PK)

RespireRx Pharmaceuticals (PK)

Elite Pharmaceuticals (QB)

Rennova Health (PK)

Asia Broadband (PK)

Bell Buckle (PK)

Progressive Care (QB)

Gold and GemStone Mining (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions